Showing results (2431-2440 of 2,709) with videos related to

Sort By:
Pageof 271
Cancer|May 14, 2026
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025Eleonora Nicolò, François Bertucci, Hamouda Boussen, et al.
Nano Letters|March 17, 2026
Revealing Electron-Electron Interactions in Graphene at Room Temperature with a Quantum Twisting MicroscopeM Lee, I Das, J Herzog-Arbeitman, et al.
La Clinica Terapeutica|October 14, 2024
Vietnam Association of Gastroenterology consensus for the diagnosis and treatment of functional dyspepsiaK-T T Tran, B H Mai, L Ta, et al.
The Lancet. Oncology|April 4, 2021
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trialThierry Andre, Mayur Amonkar, Josephine M Norquist, et al.
Gut|December 9, 2015
Intestinal microbiota contributes to individual susceptibility to alcoholic liver diseaseM Llopis, A M Cassard, L Wrzosek, et al.
Cancer Immunology Research|January 12, 2026
A randomized phase II study: CRS207/GVAX plus anti-PD1 and anti-CTLA4 recruits mesothelin- and mKRAS-specific T cells into PDACKatherine M Bever, Amanda L Huff, Ludmila Danilova, et al.
Eclinicalmedicine|May 4, 2026
Weight trajectories and obesity onset between 17 and 60 years of age, and cause-specific mortality: the Obesity and Disease Development Sweden (ODDS) pooled cohort studyHuyen T Le, Marisa da Silva, Louise Bennet, et al.
Plos One|April 26, 2019
Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammationSteven G Carmella, Alisa K Heskin, Mei Kuen Tang, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumI Stukalin, J C Wells, J Graham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2020
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic CancerAnnie A Wu, Katherine M Bever, Won Jin Ho, et al.
Pageof 271